Description
Description
A four-component co-formulation supplied for controlled research environments. Suitable for studies involving peptide characterization and method development in model systems.
Composition
- GHK-Cu: 50 mg
- KPV: 10 mg
- BPC-157: 10 mg
- TB-500 (Thymosin Beta 4): 10 mg
- Appearance: lyophilized powder in a sealed research vial
Research Focus (non-clinical)
- Combined evaluation of copper peptide, KPV tripeptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems
- Assay development, including chromatographic separation of four co-formulated peptides
- Stability characterization of a four-analyte lyophilized blend under laboratory storage conditions
- Method documentation for HPLC/LC-MS identity and purity assessments
Documentation
- Lot-specific COA available
- Batch and lot traceability
Important Notice
- For research use only
- Not for human consumption
- Not intended to diagnose, treat, cure, or prevent any disease
Quality & Manufacturing
- Lot-specific COA
- Lyophilized for transit stability; batch traceable
- Tamper-evident seal; lot & test date on each vial
- No MOQ for online orders
- Bulk orders for physical locations start at 25-unit minimum
